Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

echem (aust) pty limited - picloram hexyloxypropylamine salt; triclopyr butoxyethyl ester - emulsifiable concentrate - picloram hexyloxypropylamine salt anilide-aniline-pyrimidine active 100.0 g/l; triclopyr butoxyethyl ester pyridine-pyridinoxy active 300.0 g/l - herbicide

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - deferiprone, quantity: 1000 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; hypromellose; hyprolose; macrogol 8000; titanium dioxide; methylcellulose - ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine or in whom desferrioxamine therapy has proven ineffective.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxycycline hyclate, quantity: 115.4 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; macrogol 4000 - infections caused by the following organisms; mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus); chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone, or in combination with topical agents). borreliae (relapsing fever). calymmatobacterium (donovania) granulomatis (granuloma inguinale). infection caused by the following gram-negative microorganisms: vibrio species (chlorea), brucella sp. (brucellosis; in conjunction with streptomycin), haemophilus ducreyi (chancroid), yersinia pestis (plague), francisella turarenis (tularaemia), bartonella bacilliformis (bartonellosis), bacteroides sp. when penicillin is contraindicated, doxy-100 is an alternative drug in the treatment of infections due to : treponema pallidum (syphilis); treponema pertenue (yaws); neisseria gonorrhoea (see dosage and administration). doxy-100 is not the drug of choice in the treatment of any type of staphylococcal infection or infections due to streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, streptococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxy-100 should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a beta-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice. in acute intestinal amoebiasis, doxycycline may be a useful adjunct to amoebicides. in severe acne, doxycycline may be useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example, chloroquine.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxycycline hyclate, quantity: 57.7 mg (equivalent: doxycycline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; macrogol 4000 - infections caused by the following microorganisms: mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus): chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents). borreliae (relapsing fever); calymmatobacterium (donovania) granulomatis (granuloma inguinale). infections caused by the following gram-negative microorganisms: vibrio sp. (cholera); brucella sp. (brucellosis, in conjunction with streptomycin); haemophilus ducreyi (chancroid); yersinia pestis (plague); francisella tularensis (tularaemia); bartonella bacilliformis (bartonellosis); bacteroides sp. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: treponema pallidum (syphilis); treponema perenue (yaws); neisseria gonorrhoea (see dosage and administration). doxycycline is not the drug of choice in the treatment of any type of staphylococcal infection of infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, enterococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxycycline should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a b-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice. in acute intestinal amoebiasis doxycycline may be a useful adjunct to amoebicides. in severe acne, doxycycline may be a useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example chloroquine. note: the 50mg tablet is not a paediatric formulation.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - deferiprone, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: glycerol; hydrochloric acid; sucralose; sunset yellow fcf; peppermint oil; hyetellose; purified water; flavour - indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy; or in whom desferrioxamine therapy has proven ineffective.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - deferiprone, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sucralose; purified water; glycerol; sunset yellow fcf; hydrochloric acid; hyetellose; peppermint oil; flavour - indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy; or in whom desferrioxamine therapy has proven ineffective.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - picloram present as the potassium salt - soluble concentrate - picloram present as the potassium salt anilide/aniline-pyrimidine active 240.0 g/l - herbicide

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - deferiprone, quantity: 500 mg - tablet, film coated - excipient ingredients: titanium dioxide; macrogol 3350; hypromellose; microcrystalline cellulose; silicon dioxide; magnesium stearate - ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy; or in whom desferrioxamine therapy has proven ineffective.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

macspred pty. ltd. - metsulfuron-methyl - dry flowable - metsulfuron-methyl urea-sulfonyl active 600.0 g/kg - herbicide - barley | cereal rye | commercial/industrial land | flood plain | natural pasture (native) | right-of-way - general | triticale | - african turnip weed | alligator weed | amsinckia,yellow burrweed or burr grass | apple box | australian or native blackthorn | ball mustard | bellyache bush | bitou bush or boneseed | blackberry | blakely's red gum or gum | bracken | bridal creeper | broadleaf dock | calomba daisy | cape tulip | charlock | chickweed | chicory | crofton weed | cutleaf mignonette | darling pea | deadnettle | denseflower fumitory (red) | dwarf amaranth or boggabri weed | erodium, crowfoot or storksbill | fennel | furze or gorse | golden dodder | great mullein | gum - peppermint | hare's-ear or treacle mustard | hawthorn | inkweed | japanese sunflower | kangaroo thorn | lantana - lantana camara | lincoln weed, sand rocket or mustard | mallee catchfly | medic | messmate stringybark | mimosa pigra | mistflower or creeping crofton weed | new zealand spinach | noogoora burr | parthenium weed | paterson's curse | perennial pigweed | prickly lettuce | privet | ragwort | rough poppy | rubber vine | saltbush or annual saltbush | shepherd

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - desferrioxamine mesylate -